These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 11899853)

  • 1. [The methods of estimation and monitoring liver fibrosis in patients with chronic viral hepatitis].
    Lebensztejn DM
    Pol Merkur Lekarski; 2001 Dec; 11(66):522-5. PubMed ID: 11899853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biochemical markers of fibrosis in chronic hepatitis and liver cirrhosis of viral origin].
    Kozłowska J; Łoch T; Jabłońska J; Cianciara J
    Przegl Epidemiol; 2001; 55(4):451-8. PubMed ID: 11921731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and pathological study on liver fibrosis in viral hepatitis].
    Xin S; Mao Y; Wang L; Li Y; Li L; Yu H; Zhao M; Zhang S; Wang S; Wang X; Chen L; Zhou X; Zhou Y; Zou Z; Tang S; Huangpu Y; Zhang L
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):240-3. PubMed ID: 15617338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Respective roles of porto-septal fibrosis and centrilobular fibrosis in alcoholic liver disease.
    Michalak S; Rousselet MC; Bedossa P; Pilette C; Chappard D; Oberti F; Gallois Y; Calès P
    J Pathol; 2003 Sep; 201(1):55-62. PubMed ID: 12950017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis.
    Castera L
    J Viral Hepat; 2009 May; 16(5):300-14. PubMed ID: 19254351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy of a fibrosis serum panel (FIBROSpect II) compared with Knodell and Ishak liver biopsy scores in chronic hepatitis C patients.
    Christensen C; Bruden D; Livingston S; Deubner H; Homan C; Smith K; Oh E; Gretch D; Williams J; McMahon B
    J Viral Hepat; 2006 Oct; 13(10):652-8. PubMed ID: 16970596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients.
    Patel K; Gordon SC; Jacobson I; Hézode C; Oh E; Smith KM; Pawlotsky JM; McHutchison JG
    J Hepatol; 2004 Dec; 41(6):935-42. PubMed ID: 15582126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of fibrosis markers for staging liver fibrosis in patients with precirrhotic alcoholic liver disease.
    Lieber CS; Weiss DG; Paronetto F;
    Alcohol Clin Exp Res; 2008 Jun; 32(6):1031-9. PubMed ID: 18422837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of hepatitis C: non-invasive fibrosis markers and/or liver biopsy.
    Bedossa P
    Liver Int; 2009 Jan; 29 Suppl 1():19-22. PubMed ID: 19207962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis, and its relationship with circulating thrombocyte counts.
    Koruk M; Onuk MD; Akçay F; Savas MC
    Hepatogastroenterology; 2002; 49(48):1645-8. PubMed ID: 12397754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cirrhosis in hepatitis C virus-infected patients can be excluded using an index of standard biochemical serum markers.
    Islam S; Antonsson L; Westin J; Lagging M
    Scand J Gastroenterol; 2005 Jul; 40(7):867-72. PubMed ID: 16109665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive biochemical markers of liver fibrosis.
    Grigorescu M
    J Gastrointestin Liver Dis; 2006 Jun; 15(2):149-59. PubMed ID: 16802010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.
    Tsochatzis E; Papatheodoridis GV; Hadziyannis E; Georgiou A; Kafiri G; Tiniakos DG; Manesis EK; Archimandritis AJ
    Scand J Gastroenterol; 2008; 43(9):1128-36. PubMed ID: 18609175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver fibrosis and chronic viral hepatitis.
    Gutierrez-Reyes G; Gutierrez-Ruiz MC; Kershenobich D
    Arch Med Res; 2007 Aug; 38(6):644-51. PubMed ID: 17613356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Noninvasive estimation of fibrosis in chronic viral hepatitis].
    Risum M; Barfod TS; Lindhardt BØ
    Ugeskr Laeger; 2013 Aug; 175(34):1877-82. PubMed ID: 23952982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostic value of serum biochemical markers for liver fibrosis in patients with hepatitis B virus].
    Huang W; Gong FY
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Nov; 22(11):1034-6. PubMed ID: 12433643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Assessment and reversibility of liver fibrosis in viral hepatitis].
    Vallet-Pichard A; Pol S; Mallet V
    Rev Prat; 2011 Jan; 61(1):39-43. PubMed ID: 21452541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C.
    Myers RP; Ratziu V; Imbert-Bismut F; Charlotte F; Poynard T;
    Am J Gastroenterol; 2002 Sep; 97(9):2419-25. PubMed ID: 12358267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C.
    D'Souza RF; Feakins R; Mears L; Sabin CA; Foster GR
    Aliment Pharmacol Ther; 2005 Mar; 21(5):519-24. PubMed ID: 15740534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The APRI may be enhanced by the use of the FIBROSpect II in the estimation of fibrosis in chronic hepatitis C.
    Snyder N; Nguyen A; Gajula L; Soloway R; Xiao SY; Lau DT; Petersen J
    Clin Chim Acta; 2007 Jun; 381(2):119-23. PubMed ID: 17442291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.